McKesson unit amends credit agreement for $2,250.0 million Term B loan due 2032
On June 9, 2026, McKesson subsidiary McKesson Medical-Surgical Top Holdings entered an amendment to its April 1, 2026 credit agreement, adding a $2,250.0 million senior secured term B loan facility due 2032. The loan carries an initial rate of Adjusted Term SOFR plus 2.25% per annum and is secured by substantially all assets of the borrower and certain material U.S. subsidiaries, with total net leverage and minimum interest coverage covenants. The filing describes new debt financing but does not state its intended use or any effect on the company's results.
Key points
- Term B loan facility totals $2,250.0 million and matures in 2032.
- Initial interest rate is Adjusted Term SOFR plus 2.25% per annum; base rate option carries a 1.25% margin.
- Obligations are secured by substantially all tangible and intangible assets of the borrower and certain material U.S. subsidiaries.
- Amendment No. 1 was dated June 9, 2026; the filing was signed June 12, 2026 by CFO Kenny K. Cheung.
The filing
Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 12, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.